- Nano cap Tonix Pharmaceuticals (NASDAQ:TNXP) is up 22% after hours in reaction to its receipt of a new composition of matter patent in Europe covering TNX-102 SL.
Tonix Pharma nabs European patent covering TNX-102 SL; shares up 22% AH
Recommended For You
About TNXP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
TNXP | - | - |
Tonix Pharmaceuticals Holding Corp. |